#32_ Acreage Holdings Chief Medical Officer, Corey Burchman
Today we meet Corey Burchman, Chief Medical Officer at Acreage Holdings, a multi-state operator acquired by Canopy Growth in 2019. Corey is a nationally recognized expert on clinical cannabinoid therapeutics and has chaired multiple national conferences on the use of medical cannabis. He is an anesthesiologist and pain management physician with a career that spans over 35 years. We talk about everything from Corey's role in educating lawmakers and the medical community on the health benefit of cannabis, product innovation, his work with veterans, and the current research on cannabis as a treatment for serious diseases like cancer. https://www.linkedin.com/in/corey-burchman-b99a7aab/ https://www.acreageholdings.com/about-us/
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Today we meet Corey Burchman, Chief Medical Officer at Acreage Holdings, a multi-state operator acquired by Canopy Growth in 2019.
Corey is a nationally recognized expert on clinical cannabinoid therapeutics and has chaired multiple national conferences on the use of medical cannabis. He is an anesthesiologist and pain management physician with a career that spans over 35 years.
We talk about everything from Corey's role in educating lawmakers and the medical community on the health benefit of cannabis, product innovation, his work with veterans, and the current research on cannabis as a treatment for serious diseases like cancer.
https://www.linkedin.com/in/corey-burchman-b99a7aab/
https://www.acreageholdings.com/about-us/
The Innovating Cannabis podcast is produced and hosted by Pam Chmiel, a freelance writer and editor for the Cannabis Industry Journal.
Get in touch with [email protected].
Please like the show to help us reach more listeners🙏🏻
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.